Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Design of surface ligands for blood compatible gold nanoparticles: Effect of charge and binding energy.

Beurton J, Lavalle P, Pallotta A, Chaigneau T, Clarot I, Boudier A.

Int J Pharm. 2020 Mar 19;580:119244. doi: 10.1016/j.ijpharm.2020.119244. [Epub ahead of print]

PMID:
32201250
2.

Multiple impact pathways of the 2015-2016 El Niño in coastal Kenya.

Fortnam M, Atkins M, Brown K, Chaigneau T, Frouws A, Gwaro K, Huxham M, Kairo J, Kimeli A, Kirui B, Sheen K.

Ambio. 2020 Mar 9. doi: 10.1007/s13280-020-01321-z. [Epub ahead of print]

PMID:
32152905
3.

Harmful neutrophil subsets in patients with ischemic stroke: Association with disease severity.

Weisenburger-Lile D, Dong Y, Yger M, Weisenburger G, Polara GF, Chaigneau T, Ochoa RZ, Marro B, Lapergue B, Alamowitch S, Elbim C.

Neurol Neuroimmunol Neuroinflamm. 2019 May 15;6(4):e571. doi: 10.1212/NXI.0000000000000571. eCollection 2019 Jul.

4.

Incorporating basic needs to reconcile poverty and ecosystem services.

Chaigneau T, Coulthard S, Brown K, Daw TM, Schulte-Herbrüggen B.

Conserv Biol. 2019 Jun;33(3):655-664. doi: 10.1111/cobi.13209. Epub 2018 Nov 20.

PMID:
30125996
5.

Neutrophil hyperactivation correlates with Alzheimer's disease progression.

Dong Y, Lagarde J, Xicota L, Corne H, Chantran Y, Chaigneau T, Crestani B, Bottlaender M, Potier MC, Aucouturier P, Dorothée G, Sarazin M, Elbim C.

Ann Neurol. 2018 Feb;83(2):387-405. doi: 10.1002/ana.25159.

PMID:
29369398
6.

Regulatory T cells delay disease progression in Alzheimer-like pathology.

Dansokho C, Ait Ahmed D, Aid S, Toly-Ndour C, Chaigneau T, Calle V, Cagnard N, Holzenberger M, Piaggio E, Aucouturier P, Dorothée G.

Brain. 2016 Apr;139(Pt 4):1237-51. doi: 10.1093/brain/awv408. Epub 2016 Feb 1.

PMID:
26912648
7.

Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer's disease.

Rosset MB, Lui G, Dansokho C, Chaigneau T, Dorothée G.

J Neuroinflammation. 2015 May 16;12:95. doi: 10.1186/s12974-015-0317-5.

8.

Prolongation of prion disease-associated symptomatic phase relates to CD3+ T cell recruitment into the CNS in murine scrapie-infected mice.

Sacquin A, Chaigneau T, Defaweux V, Adam M, Schneider B, Bruley Rosset M, Eloit M.

Brain Behav Immun. 2012 Aug;26(6):919-30. doi: 10.1016/j.bbi.2012.04.002. Epub 2012 Apr 13.

9.

Th2-polarised PrP-specific transgenic T-cells confer partial protection against murine scrapie.

Iken S, Bachy V, Gourdain P, Lim A, Grégoire S, Chaigneau T, Aucouturier P, Carnaud C.

PLoS Pathog. 2011 Sep;7(9):e1002216. doi: 10.1371/journal.ppat.1002216. Epub 2011 Sep 1.

10.

Adoptive transfer of T lymphocytes sensitized against the prion protein attenuates prion invasion in scrapie-infected mice.

Gourdain P, Grégoire S, Iken S, Bachy V, Dorban G, Chaigneau T, Debiec H, Bergot AS, Renault I, Aucouturier P, Carnaud C.

J Immunol. 2009 Nov 15;183(10):6619-28. doi: 10.4049/jimmunol.0804385. Epub 2009 Oct 21.

11.

Dendritic cell-mediated-immunization with xenogenic PrP and adenoviral vectors breaks tolerance and prolongs mice survival against experimental scrapie.

Rosset MB, Sacquin A, Lecollinet S, Chaigneau T, Adam M, Crespeau F, Eloit M.

PLoS One. 2009;4(3):e4917. doi: 10.1371/journal.pone.0004917. Epub 2009 Mar 19.

12.

Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.

Sutton A, Friand V, Brulé-Donneger S, Chaigneau T, Ziol M, Sainte-Catherine O, Poiré A, Saffar L, Kraemer M, Vassy J, Nahon P, Salzmann JL, Gattegno L, Charnaux N.

Mol Cancer Res. 2007 Jan;5(1):21-33.

13.

The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9.

Brule S, Charnaux N, Sutton A, Ledoux D, Chaigneau T, Saffar L, Gattegno L.

Glycobiology. 2006 Jun;16(6):488-501. Epub 2006 Mar 2.

PMID:
16513763
14.

Syndecan-4 is a signaling molecule for stromal cell-derived factor-1 (SDF-1)/ CXCL12.

Charnaux N, Brule S, Hamon M, Chaigneau T, Saffar L, Prost C, Lievre N, Gattegno L.

FEBS J. 2005 Apr;272(8):1937-51.

15.

RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.

Charnaux N, Brule S, Chaigneau T, Saffar L, Sutton A, Hamon M, Prost C, Lievre N, Vita C, Gattegno L.

Glycobiology. 2005 Feb;15(2):119-30. Epub 2004 Sep 8.

PMID:
15355933

Supplemental Content

Loading ...
Support Center